Theraclion SA
PAR:ALTHE

Watchlist Manager
Theraclion SA Logo
Theraclion SA
PAR:ALTHE
Watchlist
Price: 0.5 EUR -3.85% Market Closed
Market Cap: €30.3m

Theraclion SA
Accrued Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Theraclion SA
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Theraclion SA
PAR:ALTHE
Accrued Liabilities
€879k
CAGR 3-Years
-8%
CAGR 5-Years
-5%
CAGR 10-Years
-2%
Edap Tms SA
NASDAQ:EDAP
Accrued Liabilities
€9.8m
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
8%
Biomerieux SA
PAR:BIM
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
SMAIO SA
PAR:ALSMA
Accrued Liabilities
€767.4k
CAGR 3-Years
16%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Amplitude Surgical SA
PAR:AMPLI
Accrued Liabilities
€9.4m
CAGR 3-Years
11%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Mauna Kea Technologies SA
PAR:ALMKT
Accrued Liabilities
€2.2m
CAGR 3-Years
23%
CAGR 5-Years
-5%
CAGR 10-Years
1%
No Stocks Found

Theraclion SA
Glance View

Market Cap
30.3m EUR
Industry
Health Care

Théraclion SA develops, manufactures, and markets oncological medical equipment. The company is headquartered in Malakoff, Ile-De-France. The company went IPO on 2014-04-25. The firm is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The firm provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.

ALTHE Intrinsic Value
0.03 EUR
Overvaluation 93%
Intrinsic Value
Price €0.5

See Also

What is Theraclion SA's Accrued Liabilities?
Accrued Liabilities
879k EUR

Based on the financial report for Dec 31, 2025, Theraclion SA's Accrued Liabilities amounts to 879k EUR.

What is Theraclion SA's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
-2%

Over the last year, the Accrued Liabilities growth was 10%. The average annual Accrued Liabilities growth rates for Theraclion SA have been -8% over the past three years , -5% over the past five years , and -2% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett